Singular Genomics Funding: $384M Raised, IPO (2021)

Singular Genomics is based in San Diego, California. It has raised $384M in total funding. Latest round: IPO.

Singular Genomics funding overview

Singular Genomics is based in San Diego, California. Singular Genomics has raised $384M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in April 2021. The round record for Singular Genomics runs through 2021; nothing later has been disclosed. Investors on record include Deerfield Management, JPMorgan Chase, Goldman Sachs, BofA Securities, Cowen, UBS. 6 distinct backers are named across the disclosed rounds.

Singular Genomics at a glance

Total raised
$384M
Latest round
IPO
Latest round date
April 2021
Headquarters
San Diego, California
Notable investors
Deerfield Management, JPMorgan Chase, Goldman Sachs, BofA Securities, Cowen, UBS

Frequently asked about Singular Genomics funding

How much has Singular Genomics raised?
Singular Genomics has raised $384M in total disclosed funding across the rounds on record.
Who has invested in Singular Genomics?
Deerfield Management, JPMorgan Chase, Goldman Sachs, BofA Securities, Cowen, UBS are named among the investors backing Singular Genomics.
What was the latest Singular Genomics funding round?
The most recent disclosed round is an IPO, announced in April 2021.
Where is Singular Genomics based?
Singular Genomics is based in San Diego, California.
When did Singular Genomics last raise?
The last disclosed Singular Genomics round closed in April 2021 at IPO.

Singular Genomics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in San Diego below to benchmark round size and investor mix.

Companies related to Singular Genomics (36)

Browse related funding lists (9)

Company funding database · Investor directory · Founder database · Mega-rounds 2026